| For: | Sahu T, Verma HK, Bhaskar LVKS. Bacterial and fungal co-infection is a major barrier in COVID-19 patients: A specific management and therapeutic strategy is required. World J Virol 2022; 11(2): 107-110 [PMID: 35433338 DOI: 10.5501/wjv.v11.i2.107] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3249/full/v11/i2/107.htm |
| Number | Citing Articles |
| 1 |
Caleb Nketia Mensah, Prince Manu, Randolf Benle, Emmanuella Aba Antwi, Michael Konney Laryea, Godfred Darko, Cedric Dzidzor Amengor, Lawrence Sheringham Borquaye. Antifungal potential of Salacia debilis extracts and compounds against Candida albicans: Biofilm inhibition, synergistic effects and computational studies. Pharmacological Research - Natural Products 2025; 9: 100448 doi: 10.1016/j.prenap.2025.100448
|
| 2 |
Luke P. Kris, Dani‐Louise Dixon, Shailesh Bihari, Jillian M. Carr. Revisiting the monocrotaline‐treated rat as a model of inflammatory lung disease: COVID‐19 and future pandemic threats?. Animal Models and Experimental Medicine 2025; 8(10): 1785 doi: 10.1002/ame2.70099
|
| 3 |
Sana Zulfiqar, Robin B. Gasser, Sahar Ghodsian, Mustafa Almukhtar, Celia Holland, Ali Rostami. Strongyloides coinfection in COVID‐19 patients treated with corticosteroids: A systematic review. Reviews in Medical Virology 2023; 33(5) doi: 10.1002/rmv.2469
|
| 4 |
Carmelo Biondo, Elena Ponzo, Angelina Midiri, Giuseppe Bernardo Ostone, Giuseppe Mancuso. The Dark Side of Nosocomial Infections in Critically Ill COVID-19 Patients. Life 2023; 13(6): 1408 doi: 10.3390/life13061408
|
